Medpace Holdings, Inc. (MEDP) Average Earnings Yield
The current earnings yield for Medpace Holdings, Inc. (MEDP) is 3.48% as of Wednesday, June 17, 2026, shown against its trailing averages.
Average Earnings Yield Chart
MEDP Earnings Yield Averages
EARNINGS YIELD CURRENT
3.48%
EARNINGS YIELD TTM
3.05%
EARNINGS YIELD 3Y
3.12%
EARNINGS YIELD 5Y
3.13%
EARNINGS YIELD 10Y
2.80%
EARNINGS YIELD 15Y
2.80%
EARNINGS YIELD 20Y
2.80%
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle